This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Boehringer Ingelheim GmbH
Drug Names(s): Rendix, BIBR 1048, Pradax (Canada), Prazaxa (Japan)
Description: Pradaxa is an oral direct thrombin inhibitor that specifically and reversibly inhibits thrombin, a key enzyme for blood clot formation.
Additional information available to subscribers only: